Rotavirus

Abstract

Rotavirus, the most common diarrheal pathogen in children worldwide, causes approximately one third of diarrhea-associated hospitalizations and 800,000 deaths per year. Because natural infection reduces the incidence and severity of subsequent episodes, rotavirus diarrhea might be controlled through vaccination. Serotypespecific immunity may play a role in protection from disease. Tetravalent rhesus-human reassortant rotavirus vaccine (RRV-TV) (which contains a rhesus rotavirus with serotype G3 specificity and reassortant rhesus-human rotaviruses with G1, G2, and G4 specificity) provides coverage against the four common serotypes of human rotavirus. In clinical trials in industrialized countries, RRV-TV conferred 49% to 68% protection against any rotavirus diarrhea and 61% to 100% protection against severe disease. This vaccine was licensed by the U.S. Food and Drug Administration on August 31, 1998, and should be cost-effective in reducing diarrheal diseases in industrialized countries. The vaccine's efficacy and cost-effectiveness in developing countries should be evaluated.

References 30

1. 1.

   Bernstein D. I., Glass R. I., Rodgers G., Davidson B. L., Sack D. A. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA. 1995;273(15):1191-1196.

   Not in our library

2. 2.

   Bernstein D. I., Smith V. E., Sander D. S., Pax K. A., Schiff G. M., Ward R. L. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis. 1990;162(5):1055-1062.

   Not in our library10.1093/infdis/162.5.1055

3. 3.

   Bishop R. F., Barnes G. L., Cipriani E., Lund J. S. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N Engl J Med. 1983;309(2):72-76.

   Not in our library10.1056/nejm198307143090203

4. 4.

   Bishop R. F., Davidson G. P., Holmes I. H., Ruck B. J. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet. 1973;2(7841):1281-1283.

   Not in our library10.1016/s0140-6736(73)92867-5

5. 5.

   Cicirello H. G., Das B. K., Gupta A., Bhan M. K., Gentsch J. R., Kumar R., Glass R. I. High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus. Pediatr Infect Dis J. 1994;13(8):720-724.

   Not in our library10.1097/00006454-199408000-00008

6. 6.

   Clark H. F., Borian F. E., Bell L. M., Modesto K., Gouvea V., Plotkin S. A. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis. 1988;158(3):570-587.

   Not in our library10.1093/infdis/158.3.570

7. 7.

   Clark H. F., Offit P. A., Ellis R. W., Eiden J. J., Krah D., Shaw A. R., Pichichero M., Treanor J. J., Borian F. E., Bell L. M. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis. 1996;174(Suppl 1):S73-S80.

   Not in our library10.1093/infdis/174.supplement_1.s73

8. 8.

   Gentsch J. R., Woods P. A., Ramachandran M., Das B. K., Leite J. P., Alfieri A., Kumar R., Bhan M. K., Glass R. I. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis. 1996;174(Suppl 1):S30-S36.

   Not in our library10.1093/infdis/174.supplement_1.s30

9. 9.

   Georges-Courbot M. C., Monges J., Siopathis M. R., Roungou J. B., Gresenguet G., Bellec L., Bouquety J. C., Lanckriet C., Cadoz M., Hessel L. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol. 1991;142(5):405-411.

   Not in our library10.1016/0923-2516(91)90008-q

10. 10.

    Herrmann J. E., Chen S. C., Fynan E. F., Santoro J. C., Greenberg H. B., Wang S., Robinson H. L. Protection against rotavirus infections by DNA vaccination. J Infect Dis. 1996;174(Suppl 1):S93-S97.

    Not in our library10.1093/infdis/174.supplement_1.s93

11. 11.

    Hilpert H., Brüssow H., Mietens C., Sidoti J., Lerner L., Werchau H. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis. 1987;156(1):158-166.

    Not in our library10.1093/infdis/156.1.158

12. 12.

    Joensuu J., Koskenniemi E., Pang X. L., Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet. 1997;350(9086):1205-1209.

    Not in our library10.1016/s0140-6736(97)05118-0

13. 13.

    Lanata C. F., Black R. E., del Aguila R., Gil A., Verastegui H., Gerna G., Flores J., Kapikian A. Z., Andre F. E. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis. 1989;159(3):452-459.

    Not in our library10.1093/infdis/159.3.452

14. 14.

    Lanata C. F., Midthun K., Black R. E., Butron B., Huapaya A., Penny M. E., Ventura G., Gil A., Jett-Goheen M., Davidson B. L. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis. 1996;174(2):268-275.

    Not in our library10.1093/infdis/174.2.268

15. 15.

    Madore H. P., Christy C., Pichichero M., Long C., Pincus P., Vosefsky D., Kapikian A. Z., Dolin R. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups. J Infect Dis. 1992;166(2):235-243.

    Not in our library10.1093/infdis/166.2.235

16. 16.

    Nakagomi O., Nakagomi T. Genetic diversity and similarity among mammalian rotaviruses in relation to interspecies transmission of rotavirus. Arch Virol. 1991;120(1-2):43-55.

    Not in our library10.1007/bf01310948

17. 17.

    Parashar U. D., Holman R. C., Clarke M. J., Bresee J. S., Glass R. I. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis. 1998;177(1):13-17.

    Not in our library10.1086/513808

18. 18.

    Pérez-Schael I., Guntiñas M. J., Pérez M., Pagone V., Rojas A. M., González R., Cunto W., Hoshino Y., Kapikian A. Z. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med. 1997;337(17):1181-1187.

    Not in our library10.1056/nejm199710233371701

19. 19.

    Ramachandran M., Das B. K., Vij A., Kumar R., Bhambal S. S., Kesari N., Rawat H., Bahl L., Thakur S., Woods P. A. Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol. 1996;34(2):436-439.

    Not in our library10.1128/jcm.34.2.436-439.1996

20. 20.

    Rennels M. B., Losonsky G. A., Levine M. M., Kapikian A. Z. Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children. Pediatr Infect Dis. 1986;5(5):587-588.

    Not in our library10.1097/00006454-198609000-00019

21. 21.

    Rennels M. B., Losonsky G. A., Young A. E., Shindledecker C. L., Kapikian A. Z., Levine M. M. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group. Am J Dis Child. 1990;144(5):601-604.

    Not in our library10.1001/archpedi.1990.02150290095037

22. 22.

    Ruuska T., Vesikari T., Delem A., André F. E., Beards G. M., Flewett T. H. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period. Scand J Infect Dis. 1990;22(3):269-278.

    Not in our library10.3109/00365549009027047

23. 23.

    Santosham M., Letson G. W., Wolff M., Reid R., Gahagan S., Adams R., Callahan C., Sack R. B., Kapikian A. Z. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis. 1991;163(3):483-487.

    Not in our library10.1093/infdis/163.3.483

24. 24.

    Tucker A. W., Haddix A. C., Bresee J. S., Holman R. C., Parashar U. D., Glass R. I. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 1998;279(17):1371-1376.

    Not in our library10.1001/jama.279.17.1371

25. 25.

    Török T. J., Kilgore P. E., Clarke M. J., Holman R. C., Bresee J. S., Glass R. I. Visualizing geographic and temporal trends in rotavirus activity in the United States, 1991 to 1996. National Respiratory and Enteric Virus Surveillance System Collaborating Laboratories. Pediatr Infect Dis J. 1997;16(10):941-946.

    Not in our library10.1097/00006454-199710000-00007

26. 26.

    Velázquez F. R., Matson D. O., Calva J. J., Guerrero L., Morrow A. L., Carter-Campbell S., Glass R. I., Estes M. K., Pickering L. K., Ruiz-Palacios G. M. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022-1028.

    Not in our library10.1056/nejm199610033351404

27. 27.

    Vesikari T., Isolauri E., D'Hondt E., Delem A., André F. E., Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet. 1984;1(8384):977-981.

    Not in our library10.1016/s0140-6736(84)92323-7

28. 28.

    Vesikari T., Isolauri E., Delem A., d'Hondt E., André F. E., Beards G. M., Flewett T. H. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr. 1985;107(2):189-194.

    Not in our library10.1016/s0022-3476(85)80123-2

29. 29.

    Vesikari T., Rautanen T., Varis T., Beards G. M., Kapikian A. Z. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age. Am J Dis Child. 1990;144(3):285-289.

    Not in our library

30. 30.

    Ward R. L. Mechanisms of protection against rotavirus in humans and mice. J Infect Dis. 1996;174(Suppl 1):S51-S58.

    Not in our library10.1093/infdis/174.supplement_1.s51

Cited by papers we hold 4

• In Vitro Antiviral Activity of Rubia Cordifolia Aerial Part Extract Against Rotavirus · 2016
  Not checked
• Burden of acute gastroenteritis among children younger than 5 years of age – a survey among parents in the United Arab Emirates · 2012
  Not checked
• Rotavirus and Severe Childhood Diarrhea · 2006
  No notice
• Global Illness and Deaths Caused by Rotavirus Disease in Children · 2003
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.